全文获取类型
收费全文 | 482篇 |
免费 | 47篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 3篇 |
妇产科学 | 2篇 |
基础医学 | 38篇 |
口腔科学 | 3篇 |
临床医学 | 20篇 |
内科学 | 61篇 |
皮肤病学 | 3篇 |
神经病学 | 21篇 |
特种医学 | 10篇 |
外科学 | 175篇 |
综合类 | 1篇 |
预防医学 | 8篇 |
眼科学 | 12篇 |
药学 | 14篇 |
肿瘤学 | 124篇 |
出版年
2024年 | 2篇 |
2023年 | 2篇 |
2022年 | 6篇 |
2021年 | 10篇 |
2020年 | 15篇 |
2019年 | 20篇 |
2018年 | 13篇 |
2017年 | 13篇 |
2016年 | 21篇 |
2015年 | 10篇 |
2014年 | 27篇 |
2013年 | 30篇 |
2012年 | 48篇 |
2011年 | 45篇 |
2010年 | 21篇 |
2009年 | 18篇 |
2008年 | 31篇 |
2007年 | 33篇 |
2006年 | 28篇 |
2005年 | 23篇 |
2004年 | 17篇 |
2003年 | 19篇 |
2002年 | 30篇 |
2001年 | 1篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1998年 | 5篇 |
1997年 | 5篇 |
1996年 | 6篇 |
1995年 | 2篇 |
1994年 | 5篇 |
1993年 | 3篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 3篇 |
1988年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1981年 | 3篇 |
1980年 | 2篇 |
1978年 | 1篇 |
1977年 | 2篇 |
1976年 | 2篇 |
排序方式: 共有530条查询结果,搜索用时 15 毫秒
71.
72.
Jatin P. Shah 《Head & neck》1980,2(3):248-252
A simplified technique is described for reconstruction of through-and-through full-thickness defects of the cheek following resection of cancer. The standard forehead flap is employed with an extended application, whereby it is folded over itself twice to provide both an inner and an outer lining. This alternative technique appears to be a reliable and quick way of obtaining both cover and lining for reconstruction of through-and-through defects of the cheek. 相似文献
73.
Hiltzik D Carlson DL Tuttle RM Chuai S Ishill N Shaha A Shah JP Singh B Ghossein RA 《Cancer》2006,106(6):1286-1295
BACKGROUND: Poorly differentiated thyroid carcinomas (PDTC) occupy an intermediate position at the prognostic level on the spectrum of thyroid carcinoma progression. However, their histologic definition is controversial. The objective of the current study was to assess the prognostic significance of PDTC defined on the basis of mitosis and necrosis and search for prognostic markers within this group of tumors that are predictive of overall survival (OS) and progression-free survival (PFS). METHODS: PDTC was defined as thyroid carcinoma with follicular cell differentiation at the histologic and/or immunohistochemical levels and displaying tumor necrosis and/or > or = 5 mitoses per 10 high-power fields (x400). Retrospective chart review and microscopic examination identified 58 patients with primary tumors meeting the above criteria and seen at the Memorial Sloan-Kettering Cancer Center between 1992 and 2004. These 58 patients were analyzed for various histologic, clinical, and imaging parameters. Each parameter was correlated with OS and PFS. RESULTS: Of the 58 patients studied, 22 (38%) patients died of disease with a 5-year OS rate of 60%. Forty-three of the 58 patients (74%) developed disease recurrence or disease progression, with a 5-year PFS rate of 25%. The median follow-up for the entire patient population was 42.6 months (range, 4-205 mos). A tumor size > 4 cm was found to be correlated with a decreased PFS time (P < 0.001). Those tumors with a capsule demonstrated a significantly improved OS compared with unencapsulated tumors (P = 0.001). The extent of capsular invasion was found to be a significant adverse factor for PFS (P = 0.05). The presence of extrathyroid extension into perithyroid soft tissue was found to be correlated with a decreased OS (P = 0.001) and PFS (P = 0.004). Of 27 patients with distant metastasis, 19 (70%) had concentrated radioactive iodine (RAI) at their metastatic sites. On multivariate analysis, extrathyroid extension and tumor size emerged as the only significant variables in predicting PFS (P = 0.04 and P = 0.01, respectively) whereas extrathyroid extension was found to be the sole independent prognostic factor for OS (P = 0.01). Growth pattern and cell type did not appear to influence outcome. CONCLUSIONS: PDTC defined on the basis of mitosis and necrosis constitutes a group of tumors that is more aggressive and homogeneous than PDTC defined by growth pattern. Within this group of patients, microstaging (tumor size, the extent of capsular invasion, and, especially, extrathyroid extension), and not growth pattern or cell type, is able to stratify patients into different prognostic categories. RAI uptake occurs in a significant number of patients with PDTC. 相似文献
74.
Ghossein RA Hiltzik DH Carlson DL Patel S Shaha A Shah JP Tuttle RM Singh B 《Cancer》2006,106(8):1669-1676
BACKGROUND: Follicular carcinomas of the thyroid gland, including its oncocytic variant (so-called Hurthle cell carcinoma), are subdivided into the indolent encapsulated ("minimally invasive") and the clinically aggressive widely invasive tumors. There are, however, cases of encapsulated follicular carcinoma that recur and metastasize. Identifying these cases at the time of diagnosis is crucial for prognostic and therapeutic considerations. Because to the authors' knowledge most studies do not focus exclusively on the encapsulated Hurthle cell carcinoma (EHC), the current study attempted to identify predictors of recurrence in EHC. METHODS: A tumor was defined as EHC if it was encapsulated, macroscopically well defined with microscopic but no macroscopic evidence of vascular or capsular invasion, and composed of > 75% follicular oncocytic cells. Retrospective chart review and microscopic examination identified 50 primary tumors meeting the above criteria at the Memorial Sloan-Kettering Cancer Center between 1967 and 2005. The cases were analyzed for various histologic and clinical parameters. Each parameter was correlated with recurrence-free survival (RFS). RESULTS: Seven of 50 (14%) patients developed disease recurrence. All patients who developed recurrence were found to have a high number of foci of vascular invasion (> or = 4). In univariate analysis, > or = 4 foci of vascular invasion (P <.0001), tumor size > 4 cm (P = .049), the presence of mitosis (P = .018), and a solid/trabecular growth pattern (P = .009) were found to be correlated with a decreased RFS. Extensive capsular invasion, gender, and age did not confer a statistically higher recurrence rate. The finding of a solid/trabecular growth and mitosis correlated with the presence of numerous foci (> or = 4) of vascular invasion (P = .01 and P = .005, respectively). CONCLUSIONS: A diligent search for vascular invasion is recommended in EHC that display mitosis or a solid/trabecular growth pattern. The presence of > or = 4 foci of vascular invasion should alert the pathologist and the clinician to a significantly higher risk of recurrence in EHC. 相似文献
75.
76.
77.
Ferlito A Robbins KT Shah JP Medina JE Silver CE Al-Tamimi S Fagan JJ Paleri V Takes RP Bradford CR Devaney KO Stoeckli SJ Weber RS Bradley PJ Suárez C Leemans CR Coskun HH Pitman KT Shaha AR de Bree R Hartl DM Haigentz M Rodrigo JP Hamoir M Khafif A Langendijk JA Owen RP Sanabria A Strojan P Vander Poorten V Werner JA Bień S Woolgar JA Zbären P Betka J Folz BJ Genden EM Talmi YP Strome M González Botas JH Olofsson J Kowalski LP Holmes JD Hisa Y Rinaldo A 《Head & neck》2011,33(3):445-450
78.
Nixon IJ Whitcher M Glick J Palmer FL Shaha AR Shah JP Patel SG Ganly I 《Annals of surgical oncology》2011,18(3):800-804
Background
Metastases to the thyroid gland are uncommon, with rates reported between 0.02% and 1.4% of surgically resected thyroid specimens. Our goal was to present our experience with surgical management of metastases to the thyroid gland.Methods
Twenty-one patients with metastatic disease to the thyroid were identified from a database of 1,992 patients with thyroid cancer who had surgery during 1986–2005. Patient, tumor, treatment, and outcome details were recorded by analysis of charts. The median age at time of surgery was 68 (range, 39–83) years; 12 were men and 9 were women.Results
All patients were managed by surgery, including lobectomy in ten patients, total thyroidectomy in six, completion thyroidectomy in two, and subtotal thyroidectomy in one. In two patients, the thyroid lesion was found to be unresectable at the time of surgery. Histopathology revealed renal cell carcinoma in ten, malignant melanoma in three, gastrointestinal adenocarcinoma in three, breast cancer in one, sarcoma in one, and adenocarcinoma from an unknown primary site in three patients. Seventeen patients have died. The cause of death in all 17 was widespread metastatic disease from their respective primary tumors. The median survival from surgery to death or last follow-up was 26.5 (range, 2–114) months.Conclusions
In patients with metastases to the thyroid gland, local control of metastatic disease in the central compartment of the neck can be successfully achieved with minimal morbidity with surgical resection in selected patients. 相似文献79.
80.
Wu JM Gandhi MP Shah AD Shah JY Fulton RG Weidner AC 《International urogynecology journal》2011,22(11):1437-1443